Trials / Completed
CompletedNCT00127179
A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)
MK0906 Phase III Double-Blind Comparative Study - Benign Prostate Hyperplasia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 600 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- Male
- Age
- 50 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to determine the efficacy and safety of an investigational drug in patients with benign prostatic hyperplasia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0906, finasteride / Duration of Treatment: 48 weeks | |
| DRUG | Comparator: placebo / Duration of Treatment: 48 weeks |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2005-07-01
- Completion
- 2005-07-25
- First posted
- 2005-08-05
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00127179. Inclusion in this directory is not an endorsement.